Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Champions Oncology (CSBR) Leases (2016 - 2025)

Historic Leases for Champions Oncology (CSBR) over the last 14 years, with Q4 2025 value amounting to $4.3 million.

  • Champions Oncology's Leases fell 2330.22% to $4.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $4.3 million, marking a year-over-year decrease of 2330.22%. This contributed to the annual value of $5.1 million for FY2025, which is 1874.6% down from last year.
  • Latest data reveals that Champions Oncology reported Leases of $4.3 million as of Q4 2025, which was down 2330.22% from $4.8 million recorded in Q3 2025.
  • Champions Oncology's 5-year Leases high stood at $8.5 million for Q2 2021, and its period low was $4.3 million during Q4 2025.
  • Moreover, its 5-year median value for Leases was $7.0 million (2023), whereas its average is $6.8 million.
  • As far as peak fluctuations go, Champions Oncology's Leases soared by 695847.46% in 2021, and later plummeted by 2330.22% in 2025.
  • Over the past 5 years, Champions Oncology's Leases (Quarter) stood at $8.3 million in 2021, then fell by 6.82% to $7.7 million in 2022, then dropped by 11.46% to $6.8 million in 2023, then decreased by 16.83% to $5.7 million in 2024, then decreased by 23.3% to $4.3 million in 2025.
  • Its Leases stands at $4.3 million for Q4 2025, versus $4.8 million for Q3 2025 and $5.1 million for Q2 2025.